Ignite Creation Date:
2025-12-24 @ 12:10 PM
Ignite Modification Date:
2025-12-24 @ 12:10 PM
Study NCT ID:
NCT03377361
Status:
COMPLETED
Last Update Posted:
2025-12-03
First Post:
2017-12-14
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-14
First Submit QC Date:
None
Study First Post Date:
2017-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-04
Results First Submit QC Date:
None
Results First Post Date:
2025-12-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED